These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2132780)

  • 1. Development of repeated acquisition methodologies: implications for the detection of drug-induced disruption in human learning.
    Bickel WK; Higgins ST; Hughes JR
    NIDA Res Monogr; 1990; 100():99-111. PubMed ID: 2132780
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of human laboratory data for the assessment of performance in workplace settings: practical and theoretical considerations.
    Heishman SJ; Henningfield JE
    NIDA Res Monogr; 1990; 100():167-74. PubMed ID: 2132770
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropsychological assessment in behavioral toxicology--developing techniques and interpretative issues.
    Lezak MD
    Scand J Work Environ Health; 1984; 10 Suppl 1():25-9. PubMed ID: 6494852
    [No Abstract]   [Full Text] [Related]  

  • 4. Zolpidem and triazolam in humans: behavioral effects and abuse liability.
    Evans SM; Griffiths RR
    NIDA Res Monogr; 1989; 95():431-2. PubMed ID: 2701312
    [No Abstract]   [Full Text] [Related]  

  • 5. High false alarm rates on a vigilance task may indicate recreational drug use.
    Damos DL; Parker ES
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):713-22. PubMed ID: 7836494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis following styrene exposure: a case report of neuropsychological sequelae.
    White DM; Daniell WE; Maxwell JK; Townes BD
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):798-806. PubMed ID: 2258438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human psychopharmacology of intranasal cocaine.
    Higgins ST; Hughes JR; Bickel WK
    NIDA Res Monogr; 1989; 95():357-8. PubMed ID: 2701303
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects.
    Kirk T; Roache JD; Griffiths RR
    J Clin Psychopharmacol; 1990 Jun; 10(3):160-7. PubMed ID: 2198294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazolam impairs delayed recall but not acquisition of various everyday memory tasks in humans.
    Davis CM; Ambros-Ingerson J; Granger R; Wu J; Zabaneh R; Abdelnaby M; Lynch G
    Exp Neurol; 1997 Nov; 148(1):124-34. PubMed ID: 9398455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
    Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ
    J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance.
    Roache JD; Cherek DR; Bennett RH; Schenkler JC; Cowan KA
    J Clin Psychopharmacol; 1993 Feb; 13(1):3-15. PubMed ID: 8486815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive dysfunction in early onset parkinsonism.
    Tsai CH; Lu CS; Hua MS; Lo WL; Lo SK
    Acta Neurol Scand; 1994 Jan; 89(1):9-14. PubMed ID: 8178636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human information-processing: some effects of methylphenidate, age, and scopolamine.
    Callaway E
    Biol Psychiatry; 1984 May; 19(5):649-62. PubMed ID: 6733179
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of attention and memory efficiency in persons with solvent neurotoxicity.
    Morrow LA; Robin N; Hodgson MJ; Kamis H
    Neuropsychologia; 1992 Oct; 30(10):911-22. PubMed ID: 1436437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological efficiency measures in male and female alcoholics.
    Glenn SW; Parsons OA
    J Stud Alcohol; 1992 Nov; 53(6):546-52. PubMed ID: 1434630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to, "Cognitive, psychomotor and subjective effects of sodium oxybate and triazolam in healthy volunteers," 2009; 206(1):141-154.
    Zvosec DL; Smith SW
    Psychopharmacology (Berl); 2009 Dec; 207(3):509-10; author reply 511-2. PubMed ID: 19777215
    [No Abstract]   [Full Text] [Related]  

  • 20. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.